Health Catalyst
Market Cap
US$1.3b
Last Updated
2019/09/20 01:28 UTC
Data Sources
Company Financials +
Executive Summary
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations.
Snowflake
Fundamentals
Reasonable growth potential with mediocre balance sheet.
Risks
- Health Catalyst has significant price volatility in the past 3 months.
Similar Companies
Share Price & News
How has Health Catalyst's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
3.2%
HCAT
0.9%
US Healthcare Services
-0.2%
US Market
1 Year Return
n/a
HCAT
8.7%
US Healthcare Services
1.1%
US Market
No trading data on HCAT.
No trading data on HCAT.
Share holder returns
| HCAT | Industry | Market | |
|---|---|---|---|
| 7 Day | 3.2% | 0.9% | -0.2% |
| 30 Day | -16.5% | -5.2% | 2.5% |
| 90 Day | n/a | -5.5% | 1.6% |
| 1 Year | n/a | 8.8%8.7% | 3.4%1.1% |
| 3 Year | n/a | 49.7%49.4% | 45.2%35.8% |
| 5 Year | n/a | 50.3%49.4% | 62.6%44.8% |
Price Volatility Vs. Market
How volatile is Health Catalyst's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Valuation
Is Health Catalyst undervalued based on future cash flows and its price relative to the stock market?
Intrinsic Value Based on Future Cash Flows
Health Catalyst's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
Health Catalyst's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
Price Based on Earnings
Health Catalyst is loss making, we can't compare its value to the US Healthcare Services industry average.
Health Catalyst is loss making, we can't compare the value of its earnings to the United States of America market.
Price Based on Expected Growth
Unable to calculate PEG ratio for Health Catalyst, we can't assess if its growth is good value.
Price Based on Value of Assets
Health Catalyst has negative assets, we can't compare the value of its assets to the US Healthcare Services industry average.
Next Steps
Future Growth
How is Health Catalyst expected to perform in the next 1 to 3 years based on estimates from 7 analysts?
36.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Estimates
Future Annual Growth Analysis
Health Catalyst's revenue is expected to grow by 19.4% yearly, however this is not considered high growth (20% yearly).
Health Catalyst's earnings are expected to grow significantly at over 20% yearly.
Health Catalyst's revenue growth is expected to exceed the United States of America market average.
Health Catalyst's earnings growth is expected to exceed the United States of America market average.
Health Catalyst's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Earnings per Share Growth Estimates
Future Return on Equity
Unable to establish if Health Catalyst will efficiently use shareholders’ funds in the future (Return on Equity greater than 20%) as it is not expected to be profitable.
Next Steps
Past Performance
How has Health Catalyst performed over the past 5 years?
-227.4%
Last years earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Health Catalyst does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
Unable to compare Health Catalyst's 1-year earnings growth to the 5-year average as it is not currently profitable.
Unable to compare Health Catalyst's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.
Return on Equity
It is difficult to establish if Health Catalyst has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
Return on Assets
It is difficult to establish if Health Catalyst has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.
Return on Capital Employed
It is difficult to establish if Health Catalyst improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
Next Steps
Financial Health
How is Health Catalyst's financial position?
Financial Position Analysis
Health Catalyst is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Health Catalyst's cash and other short term assets cover its long term commitments.
Debt to Equity History and Analysis
Health Catalyst's level of debt (173.7%) compared to net worth is high (greater than 40%).
Unable to establish if Health Catalyst's debt level has increased without past 5-year debt data.
Balance Sheet
Low level of unsold assets.
Debt is covered by short term assets, assets are 2x debt.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Health Catalyst has sufficient cash runway for 1.5 years based on current free cash flow.
Unable to confirm if Health Catalyst has at least 1 year of cash runway based on growing free cash flows without relevant data.
Next Steps
Dividend
What is Health Catalyst's current dividend yield, its reliability and sustainability?
Dividend Yield and Payments Analysis
Unable to evaluate Health Catalyst's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Health Catalyst's dividend against the top 25% market benchmark as the company has not reported any payouts.
Unable to perform a dividend volatility check as Health Catalyst has not reported any payouts.
Unable to verify if Health Catalyst's dividend has been increasing as the company has not reported any payouts.
Current Payout to Shareholders
Unable to calculate sustainability of dividends as Health Catalyst has not reported any payouts.
Future Payout to Shareholders
Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
Next Steps
Management
What is the CEO of Health Catalyst's salary, the management and board of directors tenure and is there insider trading?
2.0yrs
Average management tenure
CEO
Dan Burton (44yo)
6.9yrs
Tenure
US$4,572,740
Compensation
Mr. Daniel D. Burton, also known as Dan, has been the Chief Executive Officer of Health Catalyst, Inc. since October 2012 and has been its Director since September 2011. Mr. Burton has many years of strate ...
CEO Compensation Analysis
Dan's remuneration is about average for companies of similar size in United States of America.
Insufficient data for Dan to compare compensation growth.
Management Age and Tenure
2.0yrs
Average Tenure
53.5yo
Average Age
The tenure for the Health Catalyst management team is about average.
Board Age and Tenure
5.3yrs
Average Tenure
61yo
Average Age
The tenure for the Health Catalyst board of directors is about average.
Insider Trading
No 3 month open market individual insider trading information.
Ownership Breakdown
Management Team
Dan Orenstein (49yo)
General Counsel & Secretary
- Tenure: 3.7yrs
J. Patrick Nelli
Chief Financial Officer
- Tenure: 2yrs
- Compensation: US$1.70m
Steve Barlow
Co-Founder & Senior VP (Leave of Absence)
- Tenure: 11.7yrs
Tom Burton
Co-Founder & President of Professional Services
- Tenure: 11.7yrs
Paul Horstmeier (58yo)
Chief Operating Officer
- Tenure: 0.9yrs
Dan Burton (44yo)
CEO & Director
- Tenure: 6.9yrs
- Compensation: US$4.57m
Dale Sanders (59yo)
Chief Technology Officer
- Tenure: 0.6yrs
- Compensation: US$3.17m
Adam Brown
Senior Vice President of Investor Relations
- Tenure: 0yrs
Trudy Sullivan
Chief Communications & Diversity & Inclusion Officer
- Tenure: 0.3yrs
Jason Jones
Chief Data Scientist
- Tenure: 0.8yrs
Board Members
Promod Haque (71yo)
Director
- Tenure: 6.8yrs
Jack Kane (66yo)
Director
- Tenure: 4.7yrs
- Compensation: US$50.00k
Todd Cozzens (63yo)
Director
- Tenure: 7yrs
- Compensation: US$40.00k
D. Bullock (66yo)
Director
- Tenure: 5.3yrs
Mike Dixon (35yo)
Director
- Tenure: 8yrs
Anita Pramoda (44yo)
Director
- Tenure: 3.4yrs
- Compensation: US$35.00k
Duncan Gallagher (59yo)
Director
- Tenure: 2.3yrs
- Compensation: US$120.00k
Dan Burton (44yo)
CEO & Director
- Tenure: 6.9yrs
- Compensation: US$4.57m
Fraser Bullock (63yo)
Director
- Tenure: 5.3yrs
Timothy Ferris (56yo)
Director
- Tenure: 1.7yrs
- Compensation: US$389.97k
Company Information
Health Catalyst, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Health Catalyst, Inc.
- Ticker: HCAT
- Exchange: NasdaqGS
- Founded: 2008
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: US$1.331b
- Shares outstanding: 36.49m
- Website: https://www.healthcatalyst.com
Number of Employees
Location
- Health Catalyst, Inc.
- 3165 East Millrock Drive
- Suite 400
- Salt Lake City
- Utah
- 84121
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| HCAT | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Jul 2019 |
Biography
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/09/20 01:28 |
| End of Day Share Price | 2019/09/19 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.